Criteria and procedures for determining benefit packages in health care: A comparative perspective
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Nancy Devlin & David Parkin, 2004. "Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 437-452.
- Johannesson, Magnus, 1995. "The relationship between cost-effectiveness analysis and cost-benefit analysis," Social Science & Medicine, Elsevier, vol. 41(4), pages 483-489, August.
- Gerald Richardson & Andrea Manca, 2004. "Calculation of quality adjusted life years in the published literature: a review of methodology and transparency," Health Economics, John Wiley & Sons, Ltd., vol. 13(12), pages 1203-1210.
- Wild, Claudia & Gibis, Bernhard, 2003. "Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and Austria," Health Policy, Elsevier, vol. 63(2), pages 187-196, February.
- Niebuhr, Dea & Greß, Stefan & Rothgang, Heinz & Wasem, Jürgen, 2003. "Verfahren und Kriterien zur Konkretisierung des Leistungskatalogs in der gesetzlichen Krankenversicherung," Working papers of the ZeS 05/2003, University of Bremen, Centre for Social Policy Research (ZeS).
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Andrew McNee, 2012. "Rethinking Health Sector Wide Approaches through the lens of Aid Effectiveness," Development Policy Centre Discussion Papers 1214, Development Policy Centre, Crawford School of Public Policy, The Australian National University.
- Milewa, Timothy, 2008. "Representation and legitimacy in health policy formulation at a national level: Perspectives from a study of health technology eligibility procedures in the United Kingdom," Health Policy, Elsevier, vol. 85(3), pages 356-362, March.
- Boon, Wouter & Martins, Luis & Koopmanschap, Marc, 2015. "Governance of conditional reimbursement practices in the Netherlands," Health Policy, Elsevier, vol. 119(2), pages 180-185.
- Aarden, Erik & Van Hoyweghen, Ine & Horstman, Klasien, 2011. "Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands," Social Science & Medicine, Elsevier, vol. 72(4), pages 553-559, February.
- Stefan GreÃŸ & JÃ¼rgen Wasem & Dea Niebuhr, 2006. "Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 4(2), pages 39-47, 07.
- Katharina Fischer & Reiner Leidl, 2014. "Analysing coverage decision-making: opening Pandora’s box?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 899-906, December.
- Barnett, Pauline & Tenbensel, Tim & Cumming, Jacqueline & Clayden, Clare & Ashton, Toni & Pledger, Megan & Burnette, Mili, 2009. "Implementing new modes of governance in the New Zealand health system: An empirical study," Health Policy, Elsevier, vol. 93(2-3), pages 118-127, December.
More about this item
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:73:y:2005:i:1:p:78-91. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu) or (). General contact details of provider: http://www.elsevier.com/locate/healthpol .